Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the Elderly
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Upper respiratory tract illnesses have been associated with an increased risk of ischemic heart disease and stroke. During two influenza seasons, we assessed the influence of vaccination against influenza on the risk of hospitalization for heart disease and stroke, hospitalization for pneumonia and influenza, and death from all causes. METHODS: Cohorts of community-dwelling members of three large managed-care organizations who were at least 65 years old were studied during the 1998-1999 and 1999-2000 influenza seasons. Administrative and clinical data were used to evaluate outcomes, with multivariable logistic regression to control for base-line demographic and health characteristics of the subjects. RESULTS: There were 140,055 subjects in the 1998-1999 cohort and 146,328 in the 1999-2000 cohort, of which 55.5 percent and 59.7 percent, respectively, were immunized. At base line, vaccinated subjects were on average sicker, having higher rates of most coexisting conditions, outpatient care, and prior hospitalization for pneumonia than unvaccinated subjects. Unvaccinated subjects, however, were more likely to have been given a prior diagnosis of dementia or stroke. Vaccination against influenza was associated with a reduction in the risk of hospitalization for cardiac disease (reduction of 19 percent during both seasons [P<0.001]), cerebrovascular disease (reduction of 16 percent during the 1998-1999 season [P<0.018] and 23 percent during the 1999-2000 season [P<0.001]), and pneumonia or influenza (reduction of 32 percent during the 1998-1999 season [P<0.001] and 29 percent during the 1999-2000 season [P<0.001]) and a reduction in the risk of death from all causes (reduction of 48 percent during the 1998-1999 season [P<0.001] and 50 percent during the 1999-2000 season [P<0.001]). In analyses according to age, the presence or absence of major medical conditions at base line, and study site, the findings were consistent across all subgroups. CONCLUSIONS: In the elderly, vaccination against influenza is associated with reductions in the risk of hospitalization for heart disease, cerebrovascular disease, and pneumonia or influenza as well as the risk of death from all causes during influenza seasons. These findings highlight the benefits of vaccination and support efforts to increase the rates of vaccination among the elderly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Influenza vaccination as a population-wide prevention measure was associated with a very cost-effective reduction in clinical events.171”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [171]
Citations
Cites
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Schrag, S. D., Gorwitz, R. J., Fultz-Butts, K., & Schuchat, A. (2002) · PubMed · Cited by 3,349
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885
Holtzman, D. J., Powell‐Griner, E., Bolen, J. C., & Rhodes, L. (2000) · PubMed · Cited by 1,110
Nichol, K. L., Margolis, K. L., Wuorenma, J., & Von Sternberg, T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311206 · Cited by 996
Self-citationInfection and Atherosclerosis: Emerging Mechanistic Paradigms
Epstein, S. E., Zhou, Y. F., & Zhu, J. (1999) · Circulation · doi:10.1161/01.cir.100.4.e20 · Cited by 511
Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.
Nichol, K. L., Wuorenma, J., & von Sternberg, T. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1769 · Cited by 484
Self-citationValidation of self-report of influenza and pneumococcal vaccination status in elderly outpatients
Mac Donald, R., Baken, L., Nelson, A., & Nichol, K. L. (1999) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(98)00159-7 · Cited by 410
Self-citationAcute respiratory-tract infections and risk of first-time acute myocardial infarction
Meier, C. R., Jick, S. S., Derby, L. E., Vasilakis, C., Jick, H., Meier, C., Jick, S., Derby, L., Vasilakis, C., & Jick, H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11084-4 · Cited by 389
Vu, T., Farish, S., Jenkins, M., & Kelly, H. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00041-5 · Cited by 376
Research works printed but not linked: 7
- 2002, MMWR Morb Mortal Wkly Rep, 51, 1
- Nichol KL. Efficacy/clinical effectiveness of inactivated influenza virus vaccines in adults. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of influenza. Oxford, England: Blackwell Science, 1998:358-72.
- Becher H, 2000, J Epidemiol Biostat, 5, 277
- 1999, MMWR Morb Mortal Wkly Rep, 48, 374
- 2000, MMWR Morb Mortal Wkly Rep, 49, 375
- 1997, MMWR Morb Mortal Wkly Rep, 46, 1
- Healthy People 2010: conference edition. Vol. 1. Washington, D.C.: Department of Health and Human Services, January 2000.
Cited by
Items 101–200 of 742
Impact of influenza vaccination on major cause-specific mortality
Wang, C.-S., Wang, S., Lai, C.-T., Lin, L.-J., & Chou, P. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.10.015 · Cited by 128
“[5,9, 13 ,15,16]. Influenza is an infectious disease that can induce inflammatory responses [17,18].”
BackgroundØstbye, T., Taylor, D. H., Yancy, W. S., & Krause, K. M. (2005) · American Journal of Public Health · doi:10.2105/ajph.2004.047803 · Cited by 115
Influenza virus infection aggravates stroke outcome
Muhammad, S., Haasbach, E., Kotchourko, M., Strigli, A., Krenz, A., Ridder, D. A., Vogel, A. B., Marti, H. H., Al-Abed, Y., Planz, O., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.596783 · Cited by 116
A Population-Based Study of Neurologic Manifestations of Severe Influenza A(H1N1)pdm09 in California
Glaser, C. A., Winter, K., DuBray, K. A., Harriman, K. H., Uyeki, T. M., Sejvar, J. J., Gilliam, S., & Louie, J. K. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis454 · Cited by 118
Endothelial activation and dysfunction in the pathogenesis of influenza A virus infection
Armstrong, S. M., Darwish, I., & Lee, W. L. (2013) · Virulence · doi:10.4161/viru.25779 · Cited by 120
Global Burden of Influenza as a Cause of Cardiopulmonary Morbidity and Mortality
Fischer, W. A., Gong, M. N., Bhagwanjee, S., & Sevransky, J. (2014) · Global Heart · doi:10.1016/j.gheart.2014.08.004 · Cited by 121
“The protective effect of influenza vaccines has been most pronounced in older adults with a 19% reduced risk of hospitalization for heart disease, 23% reduction in cerebrovascular accidents, and a 50% reduction in all-cause mortality during influenza seasons [85,86].”
BackgroundInfluenza vaccine coverage rates and perceptions on vaccination in South Korea
Kee, S. Y., Lee, J. S., Cheong, H. J., Chun, B. C., Song, J. Y., Choi, W. S., Jo, Y. M., Seo, Y. B., & Kim, W. J. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.04.354 · Cited by 112
Changing the burden of COPD mortality
Mannino, D. M., & Kiri, V. A. (2006) · International Journal of COPD · doi:10.2147/copd.2006.1.3.219 · Cited by 110
“Although there are no data on the impact of infl uenza and pneumococcal vaccines on mortality in COPD patients, they have been shown to reduce mortality by 30%–40% in the elderly (Nichol et al 2003).”
BackgroundInterleukin-1 and Stroke: Biomarker, Harbinger of Damage, and Therapeutic Target
Denes, A., Pinteaux, E., Rothwell, N. J., & Allan, S. M. (2011) · Cerebrovascular Diseases · doi:10.1159/000332205 · Cited by 110
Management of community-acquired pneumonia in older adults
Simonetti, A. F., Viasus, D., García‐Vidal, C., & Carratalà, J. (2014) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936113518041 · Cited by 109
“among the elderly [Nichol et al. 2003; Lamontagne et al. 2008].”
BackgroundCapillary Dysfunction: Its Detection and Causative Role in Dementias and Stroke
Østergaard, L., Jespersen, S. N., Engedahl, T., Jiménez, E. G., Ashkanian, M., Hansen, M. B., Eskildsen, S. F., & Mouridsen, K. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0557-x · Cited by 108
2013 ESC GUIDELINES ON THE MANAGEMENT OF STABLE CORONARY ARTERY DISEASE
Montalescot, G., Sechtem, U. P., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., Mario, C. D., et al. (2014) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2014-7-7-79 · Cited by 109
Haidari, M., Wyde, P. R., Litovsky, S. H., Vela, D. C., Ali, M., Casscells, S. W., & Madjid, M. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.07.028 · Cited by 112
The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly
Ghendon, Y. Z., Kaira, A. N., & Ельшина, Г. А. (2005) · Epidemiology and Infection · doi:10.1017/s0950268805005650 · Cited by 105
Treanor, J. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1512870 · Cited by 105
The Use of Vaccines in Adult Patients With Renal Disease
Dinits-Pensy, M. Y., Forrest, G. N., Cross, A. S., & Hise, M. K. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.08.032 · Cited by 107
Derhovanessian, E., Maier, A. B., Hähnel, K., Zelba, H., de Craen, A. J. M., Roelofs, H., Slagboom, E. P., Westendorp, R. G. J., & Pawelec, G. (2013) · AGE · doi:10.1007/s11357-012-9425-7 · Cited by 102
“It is of note that six of the seven deaths within the pro-inflammatory responder group were due to cardiovascular disease or cancer compared to only three of seven deaths in individuals with an anti-inflammatory response.”
Manzoli, L., Ioannidis, J. P. A., Flacco, M. E., De Vito, C., & Villari, P. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.19917 · Cited by 97
Pneumonia in the elderly (geriatric) population
Janssens, J.-P. (2005) · Current Opinion in Internal Medicine · doi:10.1097/01.mcp.0000158254.90483.1f · Cited by 102
Chung, W., Lin, C., Hung, C.-T., Chu, Y.-H., Sung, F.-C., Kao, C.-H., & Yeh, J. (2013) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.13.0288 · Cited by 100
Yap, F. H. Y., Ho, P., Lam, K., Chan, P. K. S., Cheng, Y., & Peiris, M. J. S. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20135 · Cited by 108
“Another recent cohort study [Nichol et al., 2003] showed that influenza vaccination can also reduce the hospital admission rates for cardiac disease and stroke among the elderly.”
InfluentialIschaemic heart disease, influenza and influenza vaccination: a prospective case control study
MacIntyre, C. R., Heywood, A. E., Kovoor, P., Ridda, I., Seale, H., Tan, T. C., Gao, Z., Katelaris, A. L., Siu, D. H. W., Lo, V., et al. (2013) · Heart · doi:10.1136/heartjnl-2013-304320 · Cited by 108
Nelson, J. C., Jackson, M. L., Weiss, N. S., & Jackson, L. A. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.06.014 · Cited by 102
Association of influenza virus infection and inflammatory cytokines with acute myocardial infarction
Guan, X., Yang, W. P., Sun, X.-J., Wang, L., Ma, B.-J., Li, H., & Zhou, J. (2012) · Inflammation Research · doi:10.1007/s00011-012-0449-3 · Cited by 103
“[30] demonstrated that influenza vaccination might reduce hospitalization for cardiac disease and cerebrovascular disease and all-cause mortality in the elderly.”
BackgroundInfluenza Vaccination Compliance Among Health Care Workers in a German University Hospital
Wicker, S., Rabenau, H. F., Doerr, H. W., & Allwinn, R. (2008) · Infection · doi:10.1007/s15010-008-8200-2 · Cited by 99
Puig‐Barberà, J., Díez‐Domingo, J., Belenguer‐Varea, Á., Chavarri, G. S., Rodrigo, J. A. L., Pérez‐Hoyos, S., & Vidal, D. G. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.08.039 · Cited by 107
[Guidelines for management of community-acquired pneumonia in adults].
Lopardo, G. D., Basombrío, A., Clara, L., Desse, J., Vedia, L. D., Líbero, E. D., Gañete, M., Furst, M. J. L., Mykietiuk, A., Nemirovsky, C., et al. (2015) · PubMed · Cited by 119
Newman, T. B., & Kohn, M. A. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511759512 · Cited by 117
Recent trauma and acute infection as risk factors for childhood arterial ischemic stroke
Hills, N. K., Johnston, S. C., Sidney, S., Zielinski, B. A., & Fullerton, H. J. (2012) · Annals of Neurology · doi:10.1002/ana.23688 · Cited by 95
“Studies have demonstrated that minor infections increase the risk of AIS in adults, particularly young adults, whereas influenza vaccination reduces that risk.(13,14) Blunt injury to cervical or cerebral vessels can predispose to AIS by causing arterial dissection; screening paradigms are being established to detect s…”
BackgroundSex and gender differences in community-acquired pneumonia
Corica, B., Tartaglia, F., D’Amico, T., Romiti, G. F., & Cangemi, R. (2022) · Internal and Emergency Medicine · doi:10.1007/s11739-022-02999-7 · Cited by 109
Pneumonia, thrombosis and vascular disease
Violi, F., Cangemi, R., & Calvieri, C. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12646 · Cited by 88
Effect of influenza vaccination on hospitalizations in persons aged 50 years and older
Baxter, R. P., Ray, G. T., & FIREMAN, B. H. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.088 · Cited by 88
Hak, E., Wei, F., Nordin, J., Mullooly, J., Poblete, S., & Nichol, K. L. (2004) · The Journal of Infectious Diseases · doi:10.1086/381165 · Cited by 86
“Elsewhere, we have reported on the effectiveness of influenza vaccination among all elderly members of these HMOs [22] and among elderly members with and without certain chronic medical conditions [23], for the 1996–1997 and 1997–1998 influenza seasons, as well as the effectiveness of vaccination for reducing hospital…”
BackgroundSelf-citationArmstrong, B., Mangtani, P., FLETCHER, A. E., Kovats, S. R., McMichael, A. J., Pattenden, S., & Wilkinson, P. (2004) · BMJ · doi:10.1136/bmj.38198.594109.ae · Cited by 97
Cardiac Findings during Uncomplicated Acute Influenza in Ambulatory Adults
Ison, M. G., Campbell, V., Rembold, C., Dent, J., & Hayden, F. G. (2005) · Clinical Infectious Diseases · doi:10.1086/427282 · Cited by 82
“of underlying pulmonary disease and bacterial superinfections, influenza causes exacerbation of congestive heart failure and increased cardiac ischemia, which may contribute to an additional 90,000 deaths per year [4, 5].”
BackgroundRisk factors in coronary atherosclerosis athero-inflammation: the meeting point
Altman, R. (2003) · Thrombosis Journal · doi:10.1186/1477-9560-1-4 · Cited by 82
Puig‐Barberà, J., Díez‐Domingo, J., Pérez‐Hoyos, S., Belenguer‐Varea, Á., & Vidal, D. G. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.07.017 · Cited by 79
Effect of Influenza Vaccination on Risk of Stroke: A Systematic Review and Meta-Analysis
Lee, K. R., Bae, J. H., Hwang, I. C., Kim, K. K., Suh, H. S., & Ko, K. D. (2017) · Neuroepidemiology · doi:10.1159/000478017 · Cited by 85
Hung, I. F., Levin, Y., To, K. K., Chan, K., Zhang, J., Li, P., Li, C., Xu, T., Wong, T.-Y., & Yuen, K. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.08.014 · Cited by 80
“vaccination has recently been shown [4,5] to prevent both respiratory and vascular complications in the elderly and patients with chronic illness.”
BackgroundPrevention of Cardiovascular Events in Elderly People
Andrawes, W. F., Bussy, C., & Belmin, J. (2005) · Drugs & Aging · doi:10.2165/00002512-200522100-00005 · Cited by 104
Cardiovascular Disease in the Elderly
Schwartz, J. B., & Zipes, D. P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00080-9 · Cited by 79
Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors
Awadalla, M., Golden, D. L. A., Mahmood, S., Alvi, R. M., Mercaldo, N. D., Hassan, M. Z. O., Banerji, D., Rokicki, A., Mulligan, C. P., Murphy, S., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0535-y · Cited by 79
Influenza Vaccination in the Elderly: Impact on Hospitalisation and Mortality
Nichol, K. L. (2005) · Drugs & Aging · doi:10.2165/00002512-200522060-00004 · Cited by 88
Self-citationInfluenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19
Behrouzi, B., Campoverde, M. V. A., Liang, K., Talbot, H. K., Bogoch, I. I., McGeer, A., Fröbert, O., Loeb, M. B., Vardeny, O., Solomon, S. D., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.028 · Cited by 82
Asleep at the Switch: Local Public Health and Chronic Disease
Frieden, T. R. (2004) · American Journal of Public Health · doi:10.2105/ajph.94.12.2059 · Cited by 74
Gwini, S. M., Coupland, C. A. C., & Siriwardena, A. N. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.12.017 · Cited by 69
Reisinger, K. S., Block, S. L., Izu, A., Groth, N., & Holmes, S. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/605506 · Cited by 72
Contemporary Management of Chronic Obstructive Pulmonary Disease: Clinical Applications
Man, S. F. P., McAlister, F. A., Anthonisen, N. R., & Sin, D. D. (2003) · JAMA · doi:10.1001/jama.290.17.2313 · Cited by 69
“Influenza vaccination is associated with an approximate 20% to 30% reduction in hospitalizations from cardiac disease, and pneumonia or influenza, respectively, and an approximate 50% reduction in allcause mortality.(18) Pneumococcal vaccination is associated with a 35% reduction in disseminated pneumococcal infection…”
BackgroundKelly, H. A., Attia, J. R., Andrews, R. M., & Heller, R. F. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.11.052 · Cited by 73
Shortreed, S. M., Cook, A. J., Coley, R. Y., Bobb, J. F., & Nelson, J. C. (2019) · American Journal of Epidemiology · doi:10.1093/aje/kwy292 · Cited by 67
Chi, R., & Neuzil, K. M. (2004) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200403000-00001 · Cited by 67
Bekelis, K., Missios, S., Ahmad, J., Labropoulos, N., Schirmer, C. M., Calnan, D. R., Skinner, J., & MacKenzie, T. A. (2020) · Stroke · doi:10.1161/strokeaha.120.031217 · Cited by 78
Predictors of the antibody response to influenza vaccination in older adults with type 2 diabetes
McElhaney, J. E., Garneau, H., Camous, X., Dupuis, G., Pawelec, G., Baehl, S., Tessier, D., Frost, E. H., Frasca, D., Larbi, A., et al. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000140 · Cited by 66
Seasonal variability in spontaneous cervical artery dissection
Paciaroni, M. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.077073 · Cited by 66
“Influenza epidemics have been associated with acute myocardial infarction, and influenza vaccination has been linked to reduced risks of stroke, recurrent myocardial infarction, and cardiac disease.”
BackgroundHeymann, A. D., Shapiro, Y., Chodick, G., Shalev, V., Kokia, E., Kramer, E., & Shemer, J. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2581 · Cited by 67
“, patients with diabetes, renal disease, rheumatological disease, dementia, and stroke) reduced hospitalizations for respiratory conditions by 39% (4).”
BackgroundLudwig, A., Lucero-Obusan, C. A., Schirmer, P., Winston, C. A., & Holodniy, M. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0095-0 · Cited by 70
“Case-control, retrospective cohort, and randomized controlled trial investigations have also illustrated an increased risk for certain types of cardiac injury, including acute MI or hospital admission for heart failure during influenza seasons; such studies have included documented receipt of influenza vaccine and a d…”
BackgroundDEROUX, A., MARX, A., Burkhardt, O., Schweiger, B., Borkowski, A., Banzhoff, A., Pletz, M. W., & Lode, H. M. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.10.007 · Cited by 72
“[2] Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M.”
BackgroundKeitel, W., Treanor, J. J., Sahly, H. M. E., Gilbert, A., Meyer, A. L., PATRIARCA, P. A., & Cox, M. M. J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.037 · Cited by 64
Is influenza vaccination cost effective for healthy people between ages 65 and 74 years?
Allsup, S. J., Haycox, A. R., Regan, M., & Gosney, M. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.07.008 · Cited by 75
Two-year follow-up of the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Registry.
Gurfinkel, E., & de la Fuente, R. L. (2004) · Europe PMC (PubMed Central) · Cited by 64
Influenza Viruses, Including Avian Influenza and Swine Influenza
Treanor, J. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00165-x · Cited by 77
Influenza infection and heart failure—vaccination may change heart failure prognosis?
Kadoglou, N. P. E., Bracke, F. A. L. E., Simmers, T., Tsiodras, S., & Parissis, J. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9614-7 · Cited by 64
“Some studies have recorded higher hospitalization rates [46] and longer hospital stays [17] in unvaccinated patients with HF exacerbations.”
BackgroundSung, L., Chen, C.-I., Fang, Y.-A., Lai, C.-H., Hsu, Y.-P., Cheng, T., Miser, J. S., & Liu, J. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.04.064 · Cited by 64
Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly
Bruijn, I. D., Meyer, I., Gerez, L., Nauta, J. J. P., Giezeman‐Smits, K. M., & Palache, B. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.10.051 · Cited by 65
Örtqvist, Å., Granath, F., Askling, J., & Hedlund, J. (2007) · European Respiratory Journal · doi:10.1183/09031936.00135306 · Cited by 66
“During the first influenza season, the unadjusted effect of vaccination was ,50% (as previously reported [9]), which is in the same range as that reported by NICHOL et al. [ 8 ], for example.”
BackgroundResultInfluentialvon Baum, H., Schweiger, B., Welte, T., Marre, R., Suttorp, N., Pletz, M. W., & Ewig, S. (2010) · European Respiratory Journal · doi:10.1183/09031936.00037410 · Cited by 61
Casscells, S. W., Granger, E., Kress, A., Linton, A., Madjid, M., & Cottrell, L. (2009) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.820357 · Cited by 61
Can Vaccinations Improve Heart Failure Outcomes?
Bhatt, A. S., DeVore, A. D., Hernandez, A. F., & Mentz, R. J. (2017) · JACC Heart Failure · doi:10.1016/j.jchf.2016.12.007 · Cited by 74
The importance and implications of comparator selection in pharmacoepidemiologic research
D’Arcy, M. E., Stürmer, T., & Lund, J. L. (2018) · Current Epidemiology Reports · doi:10.1007/s40471-018-0155-y · Cited by 68
Influenza vaccine as prevention for cardiovascular diseases: Possible molecular mechanism
Veljković, V., Glišić, S., Veljković, N., Bojić, T., Dietrich, U., Perović, V., & Colombatti, A. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.007 · Cited by 59
SANDOVAL, C., Walter, S. D., KRUEGER, P., Smieja, M., SMITH, A., Yusuf, S., & Loeb, M. B. (2006) · Epidemiology and Infection · doi:10.1017/s095026880600714x · Cited by 63
Influenza Vaccination and Major Adverse Vascular Events in High-Risk Patients
Johnstone, J., Loeb, M. B., Teo, K. K., Gao, P., Dyal, L., Liu, L., Avezum, Á., Cardona-Muñóz, E. G., Sleight, P., Fagard, R. H., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.071100 · Cited by 63
Bhugra, P., Grandhi, G. R., Mszar, R., Satish, P., SINGH, R. K., Blaha, M. J., Blankstein, R., Virani, S. S., Cainzos‐Achirica, M., & Nasir, K. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019671 · Cited by 68
Influenza and its relationship to circulatory disorders
Fleming, D., Cross, K. W., & Pannell, R. S. (2004) · Epidemiology and Infection · doi:10.1017/s0950268804003231 · Cited by 65
“examined the effects of influenza vaccination on hospitalization for cardiac disease in persons o65 years during the 1998/ 1999 and 1999/2000 influenza seasons [8].”
BackgroundProbiotics to Prevent Respiratory Infections in Nursing Homes: A Pilot Randomized Controlled Trial
Wang, B., Hylwka, T., Smieja, M., Surrette, M., Bowdish, D. M. E., & Loeb, M. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15396 · Cited by 59
Chang, Y.-C., Chou, Y., Liu, J.-Y., Yeh, T., & Huang, N. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.04.014 · Cited by 62
Lee, C. S., Tkacs, N. C., & Riegel, B. J. (2009) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e31819b5419 · Cited by 71
“Furthermore, the risk of hospitalization for HF is increased during influenza season,(49) a risk that can be minimized by taking influenza vaccine.(50) As an additional source of infection, bacterial endotoxins translocate from the gut to the blood stream during episodes of congestion, a possible cause of increased le…”
BackgroundWang, I., Lin, C., Lin, P., Liang, C., Liu, Y., Chang, C., Yen, T., Morisky, D. E., Huang, C.-C., & Sung, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058317 · Cited by 64
“Systemic inflammation caused by influenza infection may lead to endothelial injury, impaired vasodilatation, and enhanced thrombosis formation [28].”
BackgroundMorrow, L. E., & Kollef, M. H. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181e6cc98 · Cited by 57
“Appropriate use of influenza and pneumococcal vaccines are recommended to reduce the prevalence of respiratory failure related to these infections, which could secondarily increase the occurrence of VAP (71, 72).”
BackgroundStatement on Seasonal Trivalent Inactivated Influenza Vaccine (TIV) for 2010-2011
NACI (2010) · Canada Communicable Disease Report · doi:10.14745/ccdr.v36i00a06 · Cited by 66
Cheng, Y., Cao, X., Cao, Z., Xu, C., Sun, L. N., Gao, Y., Wang, Y., Li, S., Wu, C., Li, X., et al. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101124 · Cited by 61
Influenza Vaccine Effectiveness in Patients on Hemodialysis
Kshirsagar, A. V. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.2238 · Cited by 56
Decreased Immune Responses to Influenza Vaccination in Patients With Heart Failure
Vardeny, O., Sweitzer, N. K., Detry, M. A., Moran, J. M., Johnson, M. R., & Hayney, M. S. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.11.009 · Cited by 56
Commentary—Anatomy of Racial Disparity in Influenza Vaccination
Fiscella, K. A. (2005) · Health Services Research · doi:10.1111/j.1475-6773.2005.0w372.x · Cited by 56
Influenza — The Goal of Control
Treanor, J. D. (2007) · New England Journal of Medicine · doi:10.1056/nejme078140 · Cited by 55
A Time-Series Analysis of Clostridium difficile and Its Seasonal Association with Influenza
Polgreen, P. M., Yang, M., Bohnett, L. C., & Cavanaugh, J. E. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/651095 · Cited by 69
“Furthermore, vaccination against influenza is associated with significant reductions in the risk of hospitalizations for heart disease and cerebrovascular disease.(27) Our results, to our knowledge, are the first to reveal a strong statistical association between influenza and CDI, with peaks in CDI activity occurring…”
ResultLiu, J.-C., Hsu, Y.-P., Kao, P.-F., Hao, W.-R., Liu, S.-H., Lin, C.-F., Sung, L.-C., & Wu, S.-Y. (2016) · Medicine · doi:10.1097/md.0000000000002868 · Cited by 53
“Influenza vaccination reduces the risk of cerebrovascular and cardiovascular diseases.(18) Vaccination predominately reduced dementia in patients aged 70 years (2–3 vaccinations: aHR1⁄4 0.”
BackgroundInactivated Influenza Vaccines: Recent Progress and Implications for the Elderly
Parodi, V., de Florentiis, D., Martini, M., & Ansaldi, F. (2011) · Drugs & Aging · doi:10.2165/11586770-000000000-00000 · Cited by 56
“Indeed, the impact of influenza is particularly heavy in patients with underlying chronic diseases, such as ischaemic heart disease, stroke, obstructive chronic bronchopneumopathy and diabetes mellitus.([3,7-9]) In the elderly, the risk of hospitalization or death for influenza/pneumonia is 3.”
BackgroundLiu, I.-F., Huang, C., Chan, W., Huang, P., Chung, C., Lin, S., Chen, J., & Leu, H. (2012) · Preventive Medicine · doi:10.1016/j.ypmed.2012.03.020 · Cited by 53
Clinical experience with inactivated, virosomal influenza vaccine
de Bruijn, I. A., Nauta, J. J. P., Cramer, W., Gerez, L., & Palache, A. M. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.020 · Cited by 53
Immunomodulation of atherosclerosis with a vaccine
Shah, P. K., Chyu, K., Fredrikson, G. N., & Nilsson, J. Å. (2005) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0372 · Cited by 53
Rodríguez, A. H., Álvarez-Rocha, L., Sirvent, J. M., Zaragoza, R., Nieto, M., Arenzana, Á., Luque, P., Socías, L., Martín, M., Navarro, D., et al. (2012) · Medicina Intensiva · doi:10.1016/j.medin.2011.11.020 · Cited by 56
Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Cardiovascular Links
Laratta, C. R., & van Eeden, S. F. (2014) · BioMed Research International · doi:10.1155/2014/528789 · Cited by 62
Patel, A. R., Breck, A., & Law, M. R. (2018) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2018.05.011 · Cited by 53
Baker, J. V., Henry, W. K., & Neaton, J. D. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328329c62f · Cited by 52
Ferdinand, K. C., Nedunchezhian, S., & Reddy, T. K. (2020) · Journal of the National Medical Association · doi:10.1016/j.jnma.2020.11.001 · Cited by 51
Prevention of hospital-acquired pneumonia
Lyons, P. G., & Kollef, M. H. (2018) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000523 · Cited by 54
Jaiswal, V., Ang, S. P., Yaqoob, S., Ishak, A., Chia, J. E., NASIR, Y. M., Anjum, Z., Alraies, M. C., Jaiswal, A., & Biswas, M. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac152 · Cited by 62
Omidi, F., Zangiabadian, M., Bonjar, A. H. S., Nasiri, M. J., & Sarmastzadeh, T. (2023) · Scientific Reports · doi:10.1038/s41598-023-47690-9 · Cited by 50
Influenza vaccination and cardiovascular risk in patients with recent TIA and stroke
Lavallée, P. C., Labreuche, J., Fox, K. M., Lavados, P. M., Mattle, H. P., Steg, P. G., & Amarenco, P. (2014) · Neurology · doi:10.1212/wnl.0000000000000456 · Cited by 50
“Two large cohort studies in populations older than 65 years suggested a reduced rate of stroke in those vaccinated against influenza.(9,10) To date, no randomized trial has tested the effect of influenza vaccination on major vascular event recurrence in stroke patients, and conflicting results have been found in patie…”
BackgroundResult
Metadata
- Authors
- Nichol, K. L., Nordin, J., Mullooly, J., Lask, R., Fillbrandt, K., & Iwane, M.
- Affiliations
- University of Minnesota (US)
- HealthPartners (US)
- Kaiser Permanente (US)
- Centers for Disease Control and Prevention (US)
- ORCID
- Nordin, James
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-04-03
- Volume
- 348
- Issue
- 14
- Pages
- 1322-1332
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2116971894
- Cited by
- 752
- References
- 42
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 10 · 2023: 15 · 2022: 14 · 2021: 17 · 2020: 23 · 2019: 26 · 2018: 29 · 2017: 25 · 2016: 19 · 2015: 33 · 2014: 29 · 2013: 42 · 2012: 50
- FWCI
- 45.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- influenza vaccination, influenza, stroke, heart disease, hospitalization, older adults, pneumonia, mortality, ischemic heart disease, cerebrovascular disease, upper respiratory tract infection, managed care, community-dwelling older adults, vaccine effectiveness, dementia, comorbidities, subgroup analysis
- MeSH terms
- Aged, Aged, 80 and over, Female, Heart Diseases, Hospitalization, Humans, Influenza, Human, Influenza Vaccines, Male, Mortality, Pneumonia, Risk, Logistic Models, Odds Ratio, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.